Addus HomeCare Corp (NASDAQ:ADUS) is a prominent provider of home care services. The company offers a range of services, including personal care, hospice, and home health services. Addus competes with other home care providers like Amedisys and LHC Group. Recently, Stevenson Roberton James, the Executive Vice President and Chief Human Resources Officer, sold 561 shares of the company's stock at $114.91 each.
Despite the sale, Addus HomeCare's financial performance remains strong. For the fourth quarter of 2025, the company reported a 25.6% increase in net service revenues, reaching $373.1 million. This growth reflects the company's ability to expand its services and capture a larger market share in the home care industry.
Addus HomeCare's net income for the fourth quarter was $29.8 million, or $1.61 per diluted share. The adjusted net income per diluted share increased by 28.3% year-over-year, reaching $1.77. This indicates the company's effective cost management and operational efficiency, contributing to its profitability.
The company's adjusted EBITDA grew by 33.3% year-over-year, amounting to $50.3 million. This substantial growth in EBITDA highlights Addus HomeCare's strong financial health and its ability to generate cash flow from its operations. Despite these positive results, the stock price has decreased by 10.57%, currently trading at $105.20.
The stock has fluctuated between $101 and $113 today, with a 52-week high of $124.44 and a low of $88.96. Addus HomeCare's market capitalization is approximately $1.94 billion, with a trading volume of 679,173 shares. This indicates a strong investor interest in the company, despite the recent decline in stock price.
